North China Pharmaceutical Company.Ltd (SHA:600812)
China flag China · Delayed Price · Currency is CNY
5.27
+0.02 (0.38%)
Apr 29, 2026, 3:00 PM CST

SHA:600812 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,3851,5411,660988.281,6835,305
Cash & Short-Term Investments
1,3851,5411,660988.281,6835,305
Cash Growth
-30.63%-7.16%68.00%-41.27%-68.28%8.10%
Accounts Receivable
2,8632,5952,2922,0662,4262,046
Other Receivables
1,3951,3821,4991,9531,9342,620
Receivables
4,2593,9773,7914,0194,3604,667
Inventory
2,4132,4112,5112,6082,5232,392
Other Current Assets
208.5201.86297.44402.34416.92348.74
Total Current Assets
8,2658,1318,2598,0188,98312,712
Property, Plant & Equipment
6,7406,8807,2037,4737,8698,251
Long-Term Investments
1,2671,2521,2051,220917.98875.9
Goodwill
---3.343.343.34
Other Intangible Assets
2,9883,0242,7561,9751,6501,344
Long-Term Deferred Tax Assets
50.8949.1572.4352.1150.2745.03
Long-Term Deferred Charges
2,1412,0551,9182,1571,6881,639
Other Long-Term Assets
--58.5558.5558.758.83
Total Assets
21,45221,39221,47120,95721,22124,930
Accounts Payable
2,4302,4512,2952,4902,7832,891
Accrued Expenses
189.62243.87202.93200.38238.11299.84
Short-Term Debt
6,3666,2427,0955,4685,2767,627
Current Portion of Long-Term Debt
1,894-448.191,0372,9302,323
Current Portion of Leases
--184.3262.95300.15199.12
Current Income Taxes Payable
63.32-16.0234.5846.4237.27
Current Unearned Revenue
164.98161.48281.75313.25295.87257.75
Other Current Liabilities
328.743,301438.25462.89540.12604.85
Total Current Liabilities
11,43712,39910,96210,26912,40914,240
Long-Term Debt
2,8521,8773,4594,0812,1293,301
Long-Term Leases
124.53124.43263.53299.16413.39326.74
Long-Term Unearned Revenue
88.3789.874.0236.8140.0644.44
Long-Term Deferred Tax Liabilities
0.550.5529.1---
Other Long-Term Liabilities
16.1816.189.740.90.90.9
Total Liabilities
14,51814,50714,79714,68614,99317,913
Common Stock
1,7161,7161,7161,7161,7161,716
Additional Paid-In Capital
3,8703,8703,8623,8993,8863,886
Retained Earnings
-29.71-65.19-196.77-306.61-311.5480.68
Comprehensive Income & Other
-6.01-5.518.267.049.52.94
Total Common Equity
5,5505,5155,3895,3155,3006,085
Minority Interest
1,3841,3701,285955.11928.25931.75
Shareholders' Equity
6,9346,8856,6756,2706,2287,017
Total Liabilities & Equity
21,45221,39221,47120,95721,22124,930
Total Debt
11,2378,24311,45011,14811,04913,777
Net Cash (Debt)
-9,852-6,702-9,790-10,159-9,366-8,472
Net Cash Per Share
-5.76-3.92-5.70-6.23-5.46-4.98
Filing Date Shares Outstanding
1,6891,6751,7161,7161,7161,716
Total Common Shares Outstanding
1,6891,6751,7161,7161,7161,716
Working Capital
-3,171-4,268-2,702-2,251-3,426-1,528
Book Value Per Share
3.293.293.143.103.093.55
Tangible Book Value
2,5622,4902,6333,3373,6464,738
Tangible Book Value Per Share
1.521.491.531.952.132.76
Buildings
--4,4054,3574,2824,011
Machinery
--7,5496,8046,7446,416
Construction In Progress
--381.14162.35154.67672.47
Source: S&P Global Market Intelligence. Standard template. Financial Sources.